NervGen Pharma (NGENF) Short Interest Ratio & Short Volume $1.85 +0.06 (+3.35%) (As of 11/22/2024 05:33 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartShort Interest NervGen Pharma Short Interest DataNervGen Pharma (NGENF) has a short interest of 270,200 shares. This marks a -3.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 65,573 shares to cover all short positions.Current Short Interest270,200 sharesPrevious Short Interest280,200 sharesChange Vs. Previous Month-3.57%Dollar Volume Sold Short$470,148.00Short Interest Ratio2.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares61,770,000 sharesPercentage of Shares Shorted0.44%Today's Trading Volume34,417 sharesAverage Trading Volume65,573 sharesToday's Volume Vs. Average52% Short Selling NervGen Pharma? Sign up to receive the latest short interest report for NervGen Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNGENF Short Interest Over TimeNGENF Days to Cover Over TimeNGENF Percentage of Float Shorted Over Time Ad Wide Moat ResearchDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about?Get the full details now. NervGen Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024270,200 shares $470,148.00 -3.6%N/A2.6 $1.74 10/15/2024280,200 shares $504,360.00 +2.8%N/A3 $1.80 9/30/2024272,700 shares $518,130.00 +2.1%N/A4.3 $1.90 9/15/2024267,200 shares $502,336.00 -0.3%N/A2.7 $1.88 8/31/2024268,000 shares $557,440.00 -1.1%N/A4.8 $2.08 8/15/2024270,900 shares $574,037.10 -0.3%N/A2.9 $2.12 Get the Latest News and Ratings for NGENF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024271,700 shares $562,419.00 -28.0%N/A4.6 $2.07 7/15/2024377,500 shares $856,925.00 +10.7%N/A1.7 $2.27 6/30/2024340,900 shares $674,982.00 -10.0%N/A2.1 $1.98 6/15/2024378,700 shares $640,003.00 +27.8%N/A1.5 $1.69 5/31/2024296,400 shares $423,852.00 +5.3%N/A1.5 $1.43 5/15/2024281,500 shares $433,510.00 +1.9%N/A3.7 $1.54 4/30/2024276,400 shares $420,128.00 +301.2%N/A2.9 $1.52 4/15/202468,900 shares $103,350.00 -83.5%N/A0.6 $1.50 3/31/2024416,300 shares $670,243.00 +67.8%N/A1.3 $1.61 3/15/2024248,100 shares $474,069.48 +151.4%N/A2.3 $1.91 2/29/202498,700 shares $251,685.00 +296.4%N/A0.9 $2.55 2/15/202424,900 shares $63,412.83 +38.3%N/A0.1 $2.55 1/15/202444,600 shares $88,085.00 -1.8%N/A0.3 $1.98 12/31/202345,400 shares $92,616.00 +1,791.7%N/A0.2 $2.04 12/15/20232,400 shares $2,955.60 +700.0%N/A0 $1.23 11/30/2023300 shares $393.00 -96.0%N/A0 $1.31 11/15/20237,400 shares $10,567.20 +13.9%N/A0.1 $1.43 10/31/20236,500 shares $8,710.00 +333.3%N/A0.1 $1.34 10/15/20231,500 shares $1,943.40 -81.9%N/A0 $1.30 9/30/20238,300 shares $11,715.45 +6.4%N/A0.2 $1.41 9/15/20237,800 shares $11,934.00 -57.1%N/A0.1 $1.53 8/31/202318,200 shares $27,614.86 +237.0%N/A0.2 $1.52 8/15/20235,400 shares $7,162.02 -79.6%N/A0.1 $1.33 7/31/202326,500 shares $34,185.00 +6.4%N/A1 $1.29 7/15/202324,900 shares $32,619.00 -2.7%N/A0.8 $1.31 6/30/202325,600 shares $31,744.00 -20.0%N/A0.4 $1.24 6/15/202332,000 shares $41,600.00 -32.9%N/A1.2 $1.30 5/31/202347,700 shares $62,010.00 +166.5%N/A1.1 $1.30 5/15/202317,900 shares $20,943.00 +96.7%N/A0.4 $1.17 4/30/20239,100 shares $10,556.00 -50.5%N/A0.1 $1.16 4/15/202318,400 shares $24,381.84 +318.2%N/A0.4 $1.33 3/31/20234,400 shares $5,425.20 +7.3%N/A0.1 $1.23 3/15/20234,100 shares $5,104.50 -33.9%N/A0.1 $1.25 2/28/20236,200 shares $8,556.00 +463.6%N/A0.1 $1.389 hidden AI stocks set to thrive in Trump’s new era (Ad)AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now 2/15/20231,100 shares $1,606.00 -38.9%N/A0 $1.46 1/31/20231,800 shares $2,907.00 +200.0%N/A0 $1.62 1/15/2023600 shares $864.00 -83.8%N/A0 $1.44 12/30/20223,700 shares $4,403.00 +516.7%N/A0.1 $1.19 12/15/2022600 shares $720.00 -81.8%N/A0 $1.20 11/30/20223,300 shares $4,686.00 -13.2%N/A0.1 $1.42 11/15/20223,800 shares $4,959.00 +111.1%N/A0.1 $1.31 10/31/20221,800 shares $2,358.00 -56.1%N/A0.1 $1.31 10/15/20224,100 shares $5,084.00 -73.6%N/A0.1 $1.24 9/30/202215,500 shares $20,770.00 +453.6%N/A0.2 $1.34 9/15/20222,800 shares $4,125.24 -42.9%N/A0.1 $1.47 8/31/20224,900 shares $7,399.00 No ChangeN/A0.1 $1.51 7/31/202210,500 shares $17,640.00 -34.4%N/A0.1 $1.68 7/15/202216,000 shares $24,160.00 -67.8%N/A0.1 $1.51 6/30/202249,700 shares $74,550.00 +100.4%N/A0.3 $1.50 6/15/202224,800 shares $35,960.00 +113.8%N/A0.2 $1.45 5/31/202211,600 shares $18,328.00 +4.5%N/A0.1 $1.58 5/15/202211,100 shares $18,648.00 +40.5%N/A0.1 $1.68 4/30/20227,900 shares $13,965.62 -69.3%N/A0 $1.77 4/15/202225,700 shares $45,440.17 +403.9%N/A0.2 $1.77 3/31/20225,100 shares $7,395.00 +183.3%N/A0 $1.45 3/15/20221,800 shares $3,384.00 -63.3%N/A0 $1.88 2/28/20224,900 shares $7,938.00 +444.4%N/A0.1 $1.62 2/15/2022900 shares $1,692.00 -87.0%N/A0 $1.88 1/31/20226,900 shares $12,661.50 +165.4%N/A0.1 $1.84 1/15/20222,600 shares $5,538.00 -78.5%N/A0.1 $2.13 12/31/202112,100 shares $25,773.00 +656.3%N/A0.2 $2.13 12/15/20211,600 shares $3,296.00 -89.7%N/A0 $2.06 11/30/202115,500 shares $35,650.00 +4.0%N/A0.1 $2.30 11/15/202114,900 shares $37,101.00 +129.2%N/A0 $2.49 10/29/20216,500 shares $15,177.50 +6,400.0%N/A0 $2.34 10/15/2021100 shares $189.00 -99.4%N/A0 $1.89 9/30/202115,800 shares $29,704.00 No ChangeN/A0.3 $1.88 8/31/20211,800 shares $2,970.00 -73.5%N/A0 $1.65 8/13/20216,800 shares $11,409.72 +65.9%N/A0.2 $1.68 7/30/20214,100 shares $5,781.00 +64.0%N/A0.1 $1.41 7/15/20212,500 shares $3,506.25 No ChangeN/A0 $1.40 6/30/20212,500 shares $3,147.25 -82.0%N/A0 $1.26 6/15/202113,900 shares $17,242.95 +195.7%N/A0.1 $1.24 5/28/20214,800 shares $5,232.00 -11.1%N/A0.3 $1.09 5/14/20215,400 shares $6,345.00 +42.1%N/A0.2 $1.18 4/30/20213,800 shares $5,396.00 +65.2%N/A0.1 $1.42 4/15/20212,300 shares $3,128.00 -79.1%N/A0.1 $1.36 3/31/202111,000 shares $14,696.00 +746.2%N/A0.3 $1.34 3/15/20211,300 shares $2,014.35 -50.0%N/A0 $1.55 2/26/20212,600 shares $4,576.00 -71.7%N/A0.1 $1.76 2/12/20219,200 shares $17,756.00 +70.4%N/A0.3 $1.93 1/29/20215,400 shares $10,553.22 +2,600.0%N/A0.1 $1.95 12/31/20202,100 shares $3,559.50 No ChangeN/A0.1 $1.70 11/30/2020900 shares $1,224.00 -52.6%N/A0 $1.369 hidden AI stocks set to thrive in Trump’s new era (Ad)AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now 11/15/20201,900 shares $2,717.00 -5.0%N/A0.1 $1.43 10/30/20202,000 shares $2,480.00 -59.2%N/A0.1 $1.24 10/15/20204,900 shares $5,279.75 +1,125.0%N/A0.1 $1.08 9/30/20201,700 shares $1,705.61 -95.3%N/A0.1 $1.00 9/15/202035,800 shares $29,714.00 +118.3%N/A0.9 $0.83 8/31/202016,400 shares $10,610.80 +720.0%N/A1 $0.65 8/14/20202,000 shares $1,260.00 +81.8%N/A0 $0.63 NGENF Short Interest - Frequently Asked Questions What is NervGen Pharma's current short interest? Short interest is the volume of NervGen Pharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 270,200 shares of NGENF short. Learn More on NervGen Pharma's current short interest. What is a good short interest ratio for NervGen Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGENF shares currently have a short interest ratio of 3.0. Learn More on NervGen Pharma's short interest ratio. Is NervGen Pharma's short interest increasing or decreasing? NervGen Pharma saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 270,200 shares, a decline of 3.6% from the previous total of 280,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NervGen Pharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to NervGen Pharma: ANEW Medical, Inc. (1.67%), NovaBay Pharmaceuticals, Inc. (18.15%), Rigel Pharmaceuticals, Inc. (3.83%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short NervGen Pharma stock? Short selling NGENF is an investing strategy that aims to generate trading profit from NervGen Pharma as its price is falling. NGENF shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NervGen Pharma? A short squeeze for NervGen Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NGENF, which in turn drives the price of the stock up even further. How often is NervGen Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGENF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ANEW Medical Short Interest Data NovaBay Pharmaceuticals Short Interest Data 180 Life Sciences Short Interest Data 3SBio Short Interest Data Algernon Pharmaceuticals Short Interest Data Alpha Tau Medical Short Interest Data Anew Medical Short Interest Data Apollomics Short Interest Data Ascentage Pharma Group International Short Interest Data Ascletis Pharma Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NGENF) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NervGen Pharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share NervGen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NGENF Stock Alerts